Exchange: NASDAQ·Updated 07:59 PM EST

BPTHBio-Path Holdings Inc

$0.21
$0.4232
(66.83%)
Today
Closed $0.21
$0.0042
(2.00%)
After Hours
Reported EarningsMay 15
Mkt Cap$2.36M
Vol6.93M

About

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1

Frequently Asked Questions

What is Market Cap of Bio-Path Holdings Inc?
What is the 52-week high for Bio-Path Holdings Inc?
What is the 52-week low for Bio-Path Holdings Inc?
What is Bio-Path Holdings Inc stock price today?
What was Bio-Path Holdings Inc stock price yesterday?
What is the PE ratio of Bio-Path Holdings Inc?
What is the Price-to-Book ratio of Bio-Path Holdings Inc?
What is the 50-day moving average of Bio-Path Holdings Inc?
How many employees does Bio-Path Holdings Inc have?

Advertisement|Remove ads.